ARIMIDEX Study ( Non-interventional Study to Evaluate Arimidex in Adjuvant Therapy in Partial or Complete Response or Stabilized Disease After First Line Chemotherapy in Postmenopausal Women With Advanced Breast Cancer)
N/A
N/A
N/A
N/A
N/A
Not Enrolling
Female
Advanced Breast Cancer
Female
Advanced Breast Cancer
Trial Information
ARIMIDEX Study ( Non-interventional Study to Evaluate Arimidex in Adjuvant Therapy in Partial or Complete Response or Stabilized Disease After First Line Chemotherapy in Postmenopausal Women With Advanced Breast Cancer)
Inclusion Criteria:
- Patients to be included in the program are that ones according to the indications
specified in the Romanian anastrozole (Arimidex) approved SmPC (attached to the
protocol)and who are already treated with anastrozole for at least 1 month before
inclusion in this program/non-interventional study.
Exclusion Criteria:
- Patients not to be included in the programme: patients who have a known
hypersensitivity to anastrozole (Arimidex®) or any of its excipients.
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Authority:
Romania: National Medicines Agency
Study ID:
NIS-ARO-HCH-2006/1
NCT ID:
NCT00562458
Start Date:
December 2006
Completion Date:
Related Keywords:
- Advanced Breast Cancer
- Advanced breast cancer
- Advanced breast cancer in postmenopausal women
- Breast Neoplasms
Name | Location |
|---|
